A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease. (Q53348639)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease. |
scientific article |
Statements
A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease. (English)
1 reference
1 reference
D Koper
1 reference
E Ruether
1 reference
R Husmann
1 reference
E Kinzler
1 reference
E Diabl
1 reference
D Klingler
1 reference
J Spatt
1 reference
R Ritter
1 reference
R Schmidt
1 reference
Z Taneri
1 reference
W Winterer
1 reference
M Rainer
1 reference
H Moessler
1 reference
1 September 2001
1 reference
16
1 reference
5
1 reference
253-263
1 reference
Identifiers
1 reference